Literature DB >> 33764989

Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis.

Xiaolan Zheng1,2, Jinhui Li1,2, Peng Yue1,2, Lei Liu1,2, Jiawen Li1,2, Kaiyu Zhou1,2, Yimin Hua1,2, Yifei Li1,2.   

Abstract

BACKGROUND: Coronary artery lesion (CAL) caused by Kawasaki disease (KD) is a leading cause of acquired heart disease in children. Initial treatment of intravenous immunoglobulin (IVIG) can reduce the incidence of CAL. Although most of the current studies have shown a certain correlation between CAL and IVIG resistance, the conclusions are not completely consistent. Thus, we performed this meta-analysis to evaluate the association between IVIG resistance and CAL in KD.
METHODS: PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, and China National Knowledge Infrastructure through April 21, 2020 were searched to detect relevant studies. Data analysis was performed with STATA 15.1.
RESULTS: A total of 53 relevant studies were eligible to this analysis, including 30312 KD patients, of which 4750 were IVIG resistance and 25562 were responders. There was a significant difference found between IVIG resistance and IVIG response groups in the incidence of CAL (P < 0.001, odds ratio (OR), 3.89; 95% confidence interval (CI) (3.18, 4.75)). The heterogeneity test results showed that the I2 value was 74.8%. The meta-regression analysis showed that the study regions might be the sources of heterogeneity. The subgroup analysis suggested that the incidence of CAL in the IVIG resistance group was still higher than that in the IVIG response group under different regions, IVIG resistance diagnostic criteria, CAL diagnostic criteria, and study types. Meanwhile, the sensitivity analysis did not find any significant impact from every single study.
CONCLUSIONS: This is the first meta-analysis to reveal the incidence of CAL was associated with IVIG resistance in KD patients. Further well-designed studies with uniform criteria are needed to evaluate the incidence of CAL in IVIG resistant patients.

Entities:  

Year:  2021        PMID: 33764989      PMCID: PMC7993784          DOI: 10.1371/journal.pone.0248812

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  85 in total

1.  The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

Authors:  Jonathan J Deeks; Petra Macaskill; Les Irwig
Journal:  J Clin Epidemiol       Date:  2005-09       Impact factor: 6.437

2.  Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.

Authors:  Tetsuya Sano; Shunji Kurotobi; Kouji Matsuzaki; Takehisa Yamamoto; Ichiro Maki; Kazunori Miki; Shigetoyo Kogaki; Junichi Hara
Journal:  Eur J Pediatr       Date:  2006-08-01       Impact factor: 3.183

3.  Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.

Authors:  Mary Beth Son; Kimberlee Gauvreau; Jane C Burns; Elena Corinaldesi; Adriana H Tremoulet; Virginia E Watson; Annette Baker; David R Fulton; Robert P Sundel; Jane W Newburger
Journal:  J Pediatr       Date:  2010-12-03       Impact factor: 4.406

4.  N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.

Authors:  Ken Yoshimura; Takahisa Kimata; Kenji Mine; Takamichi Uchiyama; Shoji Tsuji; Kazunari Kaneko
Journal:  J Pediatr       Date:  2013-01-03       Impact factor: 4.406

5.  Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.

Authors:  Satoru Iwashima; Mituaki Kimura; Takamichi Ishikawa; Takehiko Ohzeki
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

6.  Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease.

Authors:  Tarun Sabharwal; Cedric Manlhiot; Susanne M Benseler; Pascal N Tyrrell; Nita Chahal; Rae S M Yeung; Brian W McCrindle
Journal:  Am J Cardiol       Date:  2009-12-15       Impact factor: 2.778

7.  A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis.

Authors:  Priya R Soni; Magali Noval Rivas; Moshe Arditi
Journal:  Curr Rheumatol Rep       Date:  2020-02-05       Impact factor: 4.686

8.  Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014.

Authors:  Min Kyu Kim; Min Seob Song; Gi Beom Kim
Journal:  Korean Circ J       Date:  2017-11-09       Impact factor: 3.243

9.  Evaluation of left ventricular function in immunoglobulin-resistant children with Kawasaki disease: a two-dimensional speckle tracking echocardiography study.

Authors:  Haiyong Wang; Jing Shang; Minghui Tong; Yan Song; Litao Ruan
Journal:  Clin Cardiol       Date:  2019-06-07       Impact factor: 2.882

10.  Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease.

Authors:  Hyo Min Park; Dong Won Lee; Myung Chul Hyun; Sang Bum Lee
Journal:  Korean J Pediatr       Date:  2013-02-25
View more
  4 in total

Review 1.  Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.

Authors:  E Sapountzi; L Fidani; A Giannopoulos; A Galli-Tsinopoulou
Journal:  Pediatr Cardiol       Date:  2022-07-30       Impact factor: 1.838

2.  Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease.

Authors:  Xi Chen; Lu Gao; Zhen Zhen; Ying Wang; Jia Na; Wen Yu; Xinyuan Chu; Yue Yuan; Suyun Qian
Journal:  J Inflamm Res       Date:  2022-05-06

Review 3.  Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.

Authors:  Piotr Buda; Joanna Friedman-Gruszczyńska; Janusz Książyk
Journal:  Front Med (Lausanne)       Date:  2021-11-30

4.  Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study.

Authors:  Yuhan Xia; Huixian Qiu; Zhengwang Wen; Hongying Shi; Huan Yu; Jie Li; Qihao Zhang; Jianjie Wang; Xing Rong; Rongzhou Wu; Maoping Chu
Journal:  Front Pediatr       Date:  2022-09-14       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.